Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185)
Hong Kong · Delayed Price · Currency is HKD 0.9800
+0.0500 (5.38%)
Nov 2, 2026, 3:48 PM HKT
HKG:2185 Market Cap
HKG:2185 has a market cap or net worth of 238.55 million as of November 3, 2026. It is the 33,701st most valuable company in the world and the 1,801st biggest in Hong Kong. Its market cap has decreased by 88.22% in one year.
Market Cap
238.55M
Enterprise Value
181.24M
Revenue
44.39M
Global Rank
Country Rank
#1,801 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since December 23, 2021, HKG:2185's market cap has decreased from 4.90B to 238.55M, a decrease of -95.13%. That is a compound annual growth rate of -46.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 238.55M | -83.07% |
| Dec 31, 2025 | 1.41B | 253.05% |
| Dec 31, 2024 | 399.20M | -52.05% |
| Dec 29, 2023 | 832.49M | -41.56% |
| Dec 30, 2022 | 1.42B | -78.41% |
| Dec 31, 2021 | 6.60B | 34.58% |
| Dec 23, 2021 | 4.90B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wuhan YZY Biopharma | 775.40M |
| Brii Biosciences | 725.46M |
| 3D Medicines | 661.53M |
| Kintor Pharmaceutical | 622.20M |
| Sirnaomics | 457.37M |
| Uni-Bio Science Group | 394.10M |
| B&K Corporation | 384.74M |
| Transcenta Holding | 313.81M |